According to Psychemedics's latest financial reports the company has a price-to-book ratio of 1.99.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.31 | -10.07% |
2022-12-31 | 2.57 | -19.12% |
2021-12-31 | 3.18 | 41.35% |
2020-12-31 | 2.25 | -25.09% |
2019-12-31 | 3.00 | -35.62% |
2018-12-31 | 4.66 | -23.13% |
2017-12-31 | 6.06 | -29.77% |
2016-12-31 | 8.63 | 83.32% |
2015-12-31 | 4.71 | -25.75% |
2014-12-31 | 6.34 | -0.23% |
2013-12-31 | 6.36 | 25.89% |
2012-12-31 | 5.05 | 16.97% |
2011-12-31 | 4.32 | -1.53% |
2010-12-31 | 4.38 | 6.68% |
2009-12-31 | 4.11 | 28.87% |
2008-12-31 | 3.19 | -47.23% |
2007-12-31 | 6.04 | -30.32% |
2006-12-31 | 8.67 | 8.19% |
2005-12-31 | 8.02 | -24.73% |
2004-12-31 | 10.7 | 13.31% |
2003-12-31 | 9.40 | 22.57% |
2002-12-31 | 7.67 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | 2.33 | 16.77% | ๐บ๐ธ USA |
LabCorp LH | 2.12 | 6.34% | ๐บ๐ธ USA |
RadNet RDNT | 4.39 | 120.51% | ๐บ๐ธ USA |
NeoGenomics
NEO | 1.92 | -3.48% | ๐บ๐ธ USA |
Enzo Biochem ENZ | 0.7636 | -61.68% | ๐บ๐ธ USA |